Related Experiment Videos
Expression and isolation of antimicrobial small molecules from soil DNA libraries
I A MacNeil1, C L Tiong, C Minor
1Aventis Pharmaceuticals, Cambridge, MA 02139, USA. ian.macneil@aventis.com
Journal of Molecular Microbiology and Biotechnology
|April 26, 2001
Summary
Scientists explored uncultured soil microbes to find new antimicrobials. They created a bacterial artificial chromosome library from soil DNA, discovering novel antimicrobial compounds, including indirubin, offering a new drug discovery tool.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Drug Discovery
Background:
- Natural products are vital for therapeutics, but discovery of new antimicrobial molecules has slowed.
- The vast majority of soil microbes remain uncultured, representing a significant untapped resource for novel compounds.
Purpose of the Study:
- To investigate the potential of uncultured soil microorganisms as a source of novel natural products with antimicrobial activity.
- To develop and apply a method for discovering natural products from environmental DNA.
Main Methods:
- Construction and expression of a bacterial artificial chromosome (BAC) library using DNA directly isolated from soil organisms (S-DNA) in E. coli.
- Screening of the BAC library for expressed antimicrobial activities.
- Partial characterization of active clones, including identification of expressed small molecules.
Main Results:
- Several recombinant clones expressing antimicrobial activities were identified from the S-DNA library.
- One clone (mg1.1) was found to express small molecules related to indirubin.
- Genes for natural product synthesis were successfully cloned and expressed from S-DNA in a heterologous host.
Conclusions:
- Cloning and expressing genes from S-DNA in a heterologous host is a viable strategy for discovering novel natural products.
- This approach leverages microbial diversity from uncultured soil species for drug discovery.
- The technology holds significant potential for identifying new antimicrobial agents and addressing the decline in novel drug discovery.